Today, Samsung revealed that the Food and Drug Administration had given the
go-ahead for the upcoming irregular heart rhythm notification feature for its
Galaxy Watches. This will first be available on its upcoming Galaxy Watch 6 and
be
designed to function with its FDA-cleared EKG capability.Compared to the EKG
spot-checks Apple debuted with the Series
4 in 2018, it functions more similarly to Fitbit's passive AFib monitoring fe
ature that was
introduced last year. These irregular heart rhythm messages don't need the user
to
changed names. Here's where to look for the app. For quicker access, you ma
y also